Telesis Bio Inc ROCE
Quel est le ROCE de Telesis Bio Inc?
Le ROCE de Telesis Bio Inc est -104.14%
Quelle est la définition de ROCE?
Le retour sur capital utilisé (ROCE) est un ratio financier qui mesure la rentabilité d'une entreprise et l'efficacité avec laquelle son capital est utilisé.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE des entreprises dans Health Care secteur sur NASDAQ par rapport à Telesis Bio Inc
Que fait Telesis Bio Inc?
sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.
Entreprises avec roce similaire à Telesis Bio Inc
- Smith Micro Software a ROCE de -104.82%
- Acelrx Pharmaceuticals Inc a ROCE de -104.62%
- Generic Gold a ROCE de -104.39%
- Matinas Biopharma Inc a ROCE de -104.27%
- Workhorse a ROCE de -104.20%
- KOPR Point Ventures a ROCE de -104.19%
- Telesis Bio Inc a ROCE de -104.14%
- uBid a ROCE de -103.91%
- CHF Solutions Inc a ROCE de -103.66%
- Freeport Resources a ROCE de -103.44%
- Serve Robotics Inc a ROCE de -103.42%
- Tattooed Chef a ROCE de -103.33%
- American Eagle Gold a ROCE de -103.24%